The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI) (SCI)
Spinal Cord Injuries, Hypotension, Orthostatic Hypotension
About this trial
This is an interventional treatment trial for Spinal Cord Injuries focused on measuring Transcutaneous Spinal Cord Stimulation, Spinal Stimulation, Orthostatic Hypotension, Blood Pressure, Neuromodulation
Eligibility Criteria
Inclusion Criteria: Spinal cord injury for greater than or equal to 6 months Injury level ≥ T6 (thoracic level) American Spinal Injury Association (ASIA) Impairment Scale (AIS) A-D Exhibits at least one of the following hypotensive symptoms: Baseline hypotension - resting supine or seated systolic blood pressure(SBP) < 90mmHg; SBP drop ≥ 20 mmHg within 5 minutes of assuming seated position; Symptoms of orthostasis with a drop of SBP (<90mmHg) from supine to sitting Exclusion Criteria: Current illness (infection, a pressure injury that might interfere with the intervention, a recent diagnosis of DVT/PE, etc.) Ventilator-dependent History of implanted brain/spine/nerve stimulators Cardiac pacemaker/defibrillator or intra-cardiac lines Significant coronary artery or cardiac conduction disease, a recent history of myocardial infarction Insufficient mental capacity to understand and independently provide consent Pregnancy Cancer Deemed unsuitable by study physician
Sites / Locations
- Kessler FoundationRecruiting
Arms of the Study
Arm 1
Experimental
Participants with a chronic SCI (≥ 6 months after injury)
Participants will complete three days of baseline assessments (including a baseline orthostatic test and a day of neurophysiological mapping), five days of stimulation mapping to locate the optimal spinal sites for a blood pressure response, a day of testing with stimulation applied during an orthostatic provocation and a two-week (total of six days) training period with repeated exposure to stimulation, followed by two days of additional orthostatic tests (with and without stimulation)